Colorectal Cancer
News and reporting on colorectal cancer.
In a new study, Dana Farber researchers and collaborators explain the myriad molecular reasons why KRAS-mutated cancers develop resistance to targeted therapy.
UK's NICE Recommends Approval of Opdivo, Yervoy for MSI-High, MMR-Deficient Colorectal Cancer
The combination treatment has already been approved in the US and recommended for approval in this setting in Europe.
Enhertu Benefits HER2-Positive Colorectal Cancer Patients, ASCO Data Show
The data from the Phase II trial will help drugmakers further refine the drug's dose and eligible population in colorectal cancer.
Liquid Biopsy-Guided EGFR Rechallenge Therapy Shows Benefit for Colorectal Cancer Patients
The first interventional trial to use ctDNA to recruit eligible patients for this treatment showed 30 percent observable responses and more than 60 percent disease control.
Genentech Basket Trial Identifies Impact of Co-Mutations in Dual HER2-Targeted Treatment Response
Researchers studying Perjeta and Herceptin in HER2-positive advanced solid tumors reported that the combination is efficacious in KRAS wild-type tumors.